Show Summary Details
Page of

Long-term, ambulatory, and short-burst oxygen therapy in COPD 

Long-term, ambulatory, and short-burst oxygen therapy in COPD
Long-term, ambulatory, and short-burst oxygen therapy in COPD

Cassandra N.G. Lee

and Onn Min Kon

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 19 September 2020

Long-term oxygen therapy (LTOT) has been demonstrated to improve survival in hypoxic chronic obstructive pulmonary disease (COPD) patients when used for >15 h a day.

Criteria for LTOT are a pO2 of <7.3kPa or pO2 7.3–8kPa in patients with evidence of cor pulmonale.

Ambulatory oxygen (AO) can improve desaturation and increase exercise capacity.

Short-burst oxygen therapy (SBOT) may have a place in symptom relief.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.